Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patients

被引:83
作者
Tamaki, Kentaro [1 ,2 ,3 ]
Sasano, Hironobu [2 ]
Ishida, Takanori [1 ]
Miyashita, Minoru [1 ]
Takeda, Motohiro [1 ]
Amari, Masakazu [1 ]
Tamaki, Nobumitsu [3 ]
Ohuchi, Noriaki [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Surg Oncol, Sendai, Miyagi 980, Japan
[2] Tohoku Univ Hosp, Dept Pathol, Miyagi, Japan
[3] Nahanishi Clin, Dept Breast Surg, Okinawa, Japan
关键词
RANDOMIZED CLINICAL-TRIAL; HORMONE-RECEPTORS; CARCINOMA; THERAPY; RISK; ANTICOAGULATION; CHEMOTHERAPY; TRASTUZUMAB; SAMPLES; LESIONS;
D O I
10.1111/j.1349-7006.2010.01630.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The roles of core needle biopsy (CNB) have become well established as an important preoperative diagnostic method for breast lesions. We examined the concordance of histological types, nuclear grades, hormone receptors, and human epidermal growth factor receptor 2 (HER2) status between CNB and surgical specimens in 353 cases. In addition, we analyzed the correlation between the number of CNB specimens obtained and accuracy of histological factors in order to explore the optimal number of CNB specimens. Between CNB and surgical specimens, concordance rates of histological type, nuclear grade, estrogen receptor (ER), and progesterone receptor (PgR) status (cut-off 0-< 1%, 1-10%, and 10%<), and HER2 were 84.4%, 81.3%, 92.9%, and 89.3%, respectively. In 52 of 353 patients who were histopathologically diagnosed as ductal carcinoma in situ (DCIS) by CNB, final diagnosis was changed in to invasive ductal carcinoma (IDC) in surgical specimens. Statistically significant differences were detected in the discrepancy of the following factors between CNB and subsequent surgical specimens: histological types, nuclear grade, and PgR, between patients who received four or more cores and those who had received three or less cores. In addition, a similar tendency was also detected in estrogen receptor (ER) and HER2 as in the above, and the cases that received four cores reached to 100% concordance in diagnosis between CNB and surgical specimens. Therefore, the optimal numbers of CNB were considered four at least in assessing the histological type, invasion, nuclear grade, hormone receptor status, and HER2 status of individual patients in the preoperative setting. (Cancer Sci 2010).
引用
收藏
页码:2074 / 2079
页数:6
相关论文
共 29 条
[1]  
Allred DC, 1998, MODERN PATHOL, V11, P155
[2]  
[Anonymous], 2003, WHO CLASSIFICATION T
[3]   Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays [J].
Arihiro, Koji ;
Umemura, Shinobu ;
Kurosumi, Masafumi ;
Moriya, Takuya ;
Oyama, Tetsunari ;
Yamashita, Hiroko ;
Umekita, Yoshihisa ;
Komoike, Yoshifuma ;
Shimizu, Chikako ;
Fukushima, Hisaki ;
Kajiwara, Hiroshi ;
Akiyama, Futoshi .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 127 (03) :356-365
[4]   Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC) [J].
Arnedos, M. ;
Nerurkar, A. ;
Osin, P. ;
A'Hern, R. ;
Smith, I. E. ;
Dowsett, M. .
ANNALS OF ONCOLOGY, 2009, 20 (12) :1948-1952
[5]   Efficacy of neoadjuvant trastuzumab in patients with inflammatory breast cancer: data from the NOAH (NeOAdjuvant Herceptin) Phase III trial [J].
Baselga, J. ;
Semiglazov, V. ;
Manikhas, G. M. ;
Eiermann, W. ;
Lluch, A. ;
Tjulandin, S. ;
Feyereislova, A. ;
Vanhauwere, B. ;
Valagussa, P. .
EJC SUPPLEMENTS, 2007, 5 (04) :193-193
[6]   Percutaneous core biopsy of the breast: Effect of operator experience and number of samples on diagnostic accuracy [J].
Brenner, RJ ;
Fajardo, L ;
Fisher, PR ;
Dershaw, DD ;
Evans, WP ;
Bassett, L ;
Feig, S ;
Mendelson, E ;
Jackson, V ;
Margolin, FR .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1996, 166 (02) :341-346
[7]   Fine needle aspiration or core biopsy [J].
Britton, PD .
BREAST, 1999, 8 (01) :1-4
[8]   Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer [J].
Buzdar, AU ;
Ibrahim, NK ;
Francis, D ;
Booser, DJ ;
Thomas, ES ;
Theriault, RL ;
Pusztai, L ;
Green, MC ;
Arun, BK ;
Giordano, SH ;
Cristofanilli, M ;
Frye, DK ;
Smith, TL ;
Hunt, KK ;
Singletary, SE ;
Sahin, AA ;
Ewer, MS ;
Buchholz, TA ;
Berry, D ;
Hortobagyi, GN .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3676-3685
[9]  
CAVALIERE A, 2005, CANC LETT, V14, P22
[10]   Clinical importance of HER2 immunohistologic heterogeneous expression in core-needle biopsies vs resection specimens for equivocal (immunohistochemical score 2+) cases [J].
Chivukula, Mamatha ;
Bhargava, Rohit ;
Brufsky, Adam ;
Surti, Urvashi ;
Dabbs, David J. .
MODERN PATHOLOGY, 2008, 21 (04) :363-368